According to a publication in Vaccines Today, in France, trained pharmacists will be permitted to prescribe and administer vaccines. Pharmacists played a major role in the uptake of the COVID-19 vaccines, and they’ve been granted permission to administer shots against diphtheria, tetanus, polio, pertussis, flu, HPV, measles, mumps, rubella, hepatitis A, hepatitis B, […]
Paxlovid the antiviral medication developed by Pfizer remains a very important tool in our fight against COVID-19. This medication is important in saving the lives of patients for several reasons. First, Paxlovid is an effective oral medication against COVID. This means it can easily be self administered by patients if guided by knowledgeable […]
A Pretoria High Court dismisses application brought by a physician association (IPA Foundation) that aimed at preventing pharmacists from managing and prescribing medicines to patients with HIV and tuberculosis. The approval means Patients Living With HIV (PLWH) will have increased access to their medicines at pharmacies that are taking part in the Pharmacy […]
Pfizer gets the Food and Drug Administration (FDA) approval for her vaccine against the Respiratory Syncytial Virus (RSV). The vaccine will help protect infants, pregnant women, and individuals 60 years and above from the harmful effects of RSV. RSV is a very infectious virus that affects the lungs and can lead to life […]
Introduction Paxlovid is an oral antiviral medication developed by Pfizer for the treatment of corona virus disease. To get the benefits of the medication you will have to take it for the recommended period. How is Paxlovid packaged This simply is how the medication is packed in its pack and sachet. One sachet of the […]
Research findings says people who took Paxlovid are less likely to have long COVID symptoms. The article was published in March 2023 in JAMA Internal Medicine. It revealed that high-risk patients who took Paxlovid within five days of confirming infection for COVID-19 were 26% less likely to have Long COVID symptoms after 90 days, compared […]
Jennifer Lorenzini/Reuters The U.S Food and Drug Administration (FDA) approves Paxlovid for the treatment of mild-to-moderate COVID-19. In a press release On May 25, 2023, the FDA granted Pfizer approval for its antiviral medication for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including […]
Paxlovid reduces risk of severe COVID-19 in patients with chronic health condition a new study finds. The study which was conducted by researchers at Harvard University was published in June 2023 in the Clinical Infectious Diseases Journal. This investigation will contribute to proper use of the antiviral medication in the treatment of patients in […]
Paxlovid is an oral antiviral medication for the treatment of COVID-19. It was developed by Pfizer for the treatment of mild-to-moderate COVID-19 in adults at high risk for severe disease, including hospitalization and death. The Food and Drug Administration (FDA) first made Paxlovid available in December 2021 under emergency use authorization for high-risk individuals […]
Professor Tomas Hanke of the Jenner Institute led Clinical trial shows encouraging results. The trial was conducted across four sites in Kenya, Uganda, and Zambia, and ran from August 2021 to November 2022. It aimed to assess the safety and efficacy of the HIV vaccine candidate. This study was important because there is […]